Fig. 1: Comparison between CHR and CC in the AMP SCZ Cognition Battery at baseline. | Schizophrenia

Fig. 1: Comparison between CHR and CC in the AMP SCZ Cognition Battery at baseline.

From: Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

Fig. 1

a current IQ, b verbal learning, c attention, d emotion recognition, e working memory, f processing speed, g visual memory, h motor speed, i estimated premorbid IQ, j PennCNB composite. WRAT-5 Wide Range Achievement Test, IQ Full Scale Intelligence Quotient, SPLLT Short Penn List Learning Test, SPCPTNL Short Penn Continuous Performance Test, ER40 Penn Emotion Recognition Test, SFNB Short Fractal N-Back Test, DIGSYM Digit-Symbol Test, SVOLT Short Visual Object Learning Test, SCTAP Short Computerized Finger Tapping Test. CHR Clinical High Risk, CC Community Control. Composite is the average of all tests except IQ, SPLLT, and SVOLT. Significance level “***“<0.001, “**“<0.01, “*“<0.05, “NS” > 0.05.

Back to article page